Antineoplastic and immunomodulating agents | Tenderlake

Antineoplastic and immunomodulating agents

Contract Value:
NOK 560M - 560M
Notice Type:
Contract Notice
Published Date:
31 October 2013
Closing Date:
02 December 2013
Location(s):
NO01 Oslo og Akershus (NO Norway/NORGE)
Description:

Immune modulating (disease modifying) medicines such the indication multiple sclerosis (MS) LIS-MS 1405.

The awarding authority uses Mercell Sourcing Service. In order to register your interest and get access to any documents you have to click on the link below or copy and paste it into your internet browser.

http://permalink.mercell.com/41694011.aspx. Then follow the instructions on the website.

Download full details as .pdf
The Buyer:
LIS - Legemiddelinnkjøpssamarbeid
CPV Code(s):
33652000 - Antineoplastic and immunomodulating agents